Medtronic says the approval provides more options to meet patients’ personalised needs, including those with Parkinson’s disease.

Masimo (Nasdaq: MASI)+
announced today that the FDA granted 510(k) clearance for its W1 medical watch for connectivity purposes

Researchers tested their prototype in a real world setting to assess its accuracy and determine needs for improvement.

SANTA CLARA, Calif., Aug. 9, 2024 /PRNewswire/ — Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today the enrollment of the first patients in a US pivotal study of its AI-based image analysis module for lung cancer

ASHEVILLE, N.C., Aug. 9, 2024 /PRNewswire/ — Genova Diagnostics, a global leader in clinical laboratory services, proudly announces the launch of its groundbreaking Alzheimer’s Assessment, a non-invasive blood test utilizing the p-Tau217 biomarker for early detection of Alzheimer’s disease. This initiative is enabled by a strategic partnership with Neurocode, a leading innovator in neurological diagnostics and research.

VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ — EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy life for all. EmeTerm® Smart is launching on Indiegogo as the world’s first anti-nausea smart watch.

J&J MedTech’s (NYSE: JNJ)+
DePuy Synthes unit today announced that it launched its TriLeap lower extremity anatomic plating system.

Pulse Biosciences (Nasdaq:PLSE) today announced the first completed cases in a first-in-human feasibility study of its pulsed field ablation system.